The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India
Implementing Organization
Indian Institute of Science
Principal Investigator
Prof Giridhara R Babu
Public Health Foundation of India
CO-Principal Investigator
Prof Rajesh Sundaresan
Indian Institute of Science
About
The routinely used case-based reporting and IgG serosurveys underestimate the actual prevalence of COVID-19. Simultaneous estimation of IgG antibodies and active SARS-CoV2 markers can provide a more accurate estimation. This is the first comprehensive survey providing accurate estimates of the COVID-19 burden.